Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.

ABSTRACT:

Background

Oral anticoagulation (OAC) therapy is associated with increased periprocedural risks after cardiac implantable electronic device (CIED) implantation. Patterns of anticoagulation management involving non-vitamin K antagonist oral anticoagulants (NOACs) have not been characterized.

Hypothesis

Anticoagulation strategies and outcomes differ by anticoagulant type in patients undergoing CIED implantation.

Methods

Using the nationwide Outcomes Registry for Better Informed Treatment of Atrial Fibrillation, we assessed how atrial fibrillation (AF) patients undergoing CIED implantation were cared for and their subsequent outcomes. Outcomes were compared by oral anticoagulant therapy (none, warfarin, or NOAC) as well as by anticoagulation interruption status.

Resul

SUBMITTER: Black-Maier E 

PROVIDER: S-EPMC5638096 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature